Joshua Bogus
4PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 29, 2021
An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.Taniawati Supali, Yenny Djuardi, Michael Christian
|Mar 03, 2021
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis.Alison Krentel, Nandha Basker, Madsen Beau de Rochars
|Jun 09, 2020
Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.Christine L Dubray, Anita D Sircar, Valery Madsen Beau de Rochars
|Jun 25, 2019
The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study.Gary J Weil, Joshua Bogus, Michael Christian
Pageof 1
Frequent Collaborators
3 joint publications
Gary J Weil
3 joint publications
Peter U Fischer
3 joint publications
Charles W Goss
2 joint publications
Michael Christian
2 joint publications
Christopher L King
2 joint publications
Moses Laman
2 joint publications
Leanne J Robinson
2 joint publications
Josaia Samuela
1 joint publications
Swaminathan Subramanian
1 joint publications
Christine L Dubray
